共 27 条
[1]
Apostolidis A(2016)Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014 Neurourol Urodyn 35 293-298
[2]
Apostolidis A(2006)Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 644-650
[3]
Dasgupta P(2013)OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial Eur Urol 64 249-256
[4]
Fowler CJ(2013)OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial J Urol 189 2186-2193
[5]
Chapple C(2014)OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder Int J Clin Pract 68 1246-1256
[6]
Nitti VW(2010)What treatment should we use if drugs fail for OAB; and what really works after drugs? Neurourol Urodyn 29 658-661
[7]
Sievert KD(2011)Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability Neurourol Urodyn 30 1538-1540
[8]
Bosch JL(2015)Practical aspects of botulinum toxin-A treatment in patients with overactive bladder syndrome Int Neurourol J 19 213-219
[9]
Makovey I(2000)Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 692-697
[10]
Liao CH(2014)OnabotulinumtoxinA and multiple sclerosis Ann Phys Rehabil Med 57 302-314